Tacrolimus Treatment Effectively Inhibits Progression of Obliterative Airway Disease Even at Later Stages of Disease Development

Journal of Heart and Lung Transplantation

Volumn 27, Issue 8, 2008, Pages 856-864

  Hollmén, Maria ^a   Tikkanen, Jussi M ^a   Nykänen, Antti I ^a   Koskinen, Petri K ^a,b   Lemström, Karl B ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TACROLIMUS;

ALLOIMMUNITY; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; DISEASE COURSE; DOSE RESPONSE; DRUG INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TRACHEA OBSTRUCTION; TRACHEA SURGERY;

ANIMALS; BRONCHIOLITIS OBLITERANS; CALCINEURIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REGRESSION ANALYSIS; TACROLIMUS; TRACHEA; TREATMENT OUTCOME;

EID: 47649124260     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.018     Document Type: Article

References (31)

1. Burton C.M., Carlsen J., Mortensen J., et al. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 26 (2007) 681-686
2. Hertz M.I., Boucek M.M., Edwards L.B., et al. The ISHLT transplant registry: moving forward. J Heart Lung Transplant 25 (2006) 1179-1185
3. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1-15
4. Estenne M., and Hertz M.I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166 (2002) 440-444
5. Scott L.J., McKeage K., Keam S.J., and Plosker G.L. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 63 (2003) 1247-1297
6. Revell M.P., Lewis M.E., Llewellyn-Jones C.G., Wilson I.C., and Bonser R.S. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 19 (2000) 1219-1223
7. Cairn J., Yek T., Banner N.R., Khaghani A., Hodson M.E., and Yacoub M. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J Heart Lung Transplant 22 (2003) 50-57
8. Koskinen P.K., Kallio E.A., Krebs R., and Lemstrom K.B. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am J Respir Crit Care Med 155 (1997) 303-312
9. Hertz M.I., Jessurun J., King M.B., Savik S.K., and Murray J.J. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 142 (1993) 1945-1951
10. Hele D.J., Yacoub M.H., and Belvisi M.G. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res 2 (2001) 169-183
11. Deuse T., Schrepfer S., Koch-Nolte F., et al. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation. J Heart Lung Transplant 24 (2005) 1844-1854
12. Trulock E.P. Lung transplantation. Am J Respir Crit Care Med 155 (1997) 789-818
13. Kallio E.A., Koskinen P.K., Aavik E., Vaali K., and Lemstom K.B. Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. J Clin Invest 100 (1997) 2984-2994
14. Okada Y., Zuo X.J., Marchevsky A.M., et al. Pre-transplant donor-specific transfusions induce allograft rejection and IL-2 gene expression in the WKY→F344 functional tolerance model of rat lung transplantation. Transplant Immunol 6 (1998) 137-146
15. Religa P., Bojakowski K., Bojakowska M., et al. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis. Cardiovasc Res 65 (2005) 535-545
16. Deuse T., Schrepfer S., Koch-Nolte F., et al. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease. Transplant Int 19 (2006) 310-318
17. Maasilta P.K., Salminen U.S., Lautenschlager I.T., Taskinen E.I., and Harjula A.L. Immune cells and immunosuppression in a porcine bronchial model of obliterative bronchiolitis. Transplantation 72 (2001) 998-1005
18. Tikkanen J.M., Lemström K.B., and Koskinen P.K. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type 1-dominated immune response. Am J Respir Crit Care Med 165 (2002) 724-729
19. Yousem S.A. The potential role of mast cells in lung allograft rejection. Hum Pathol 28 (1997) 179
20. Minami M., Nakahara K., Matsumura A., et al. Histamine release from pulmonary mast cells after lung transplantation in rats. J Heart Lung Transplant 14 (1995) 505
21. King M.B., Pedtke A.C., Levrey-Hadden H.L., and Hertz M.I. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus. Transplantation 74 (2002) 557-562
22. Neuringer I.P., Aris R.M., Burns K.A., et al. Epithelial kinetics in mouse heterotopic tracheal allografts. Am J Transplant 2 (2002) 410-419
23. Ibrahim L., Dominguez M., and Yacoub M. Primary human adult lung epithelial cells in vitro: response to interferon-gamma and cytomegalovirus. Immunology 79 (1993) 119-124
24. Koskinen P.K., Kallio E.A., Bruggeman C.A., and Lemstrom K.B. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am J Respir Crit Care Med 155 (1997) 2078-2088
25. Aris R.M., Walsh S., Chalermskulrat W., Hathwar V., and Neuringer I.P. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 166 (2002) 417-422
26. Asahara T., Bauters C., Pastore C., et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91 (1995) 2793-2801
27. Asahara T., Chen D., Tsurumi Y., et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94 (1996) 3291-3302
28. Tsurumi Y., Murohara T., Krasinski K., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3 (1997) 879-886
29. van der Zee R., Murohara T., Luo Z., et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95 (1997) 1030-1037
30. Krebs R., Tikkanen J.M., Nykanen A.I., et al. Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. Am J Respir Crit Care Med 171 (2005) 1421-1429
31. Ward C., Forrest I.A., Murphy D.M., et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 60 (2005) 865-871